Subject: VPH newsletter - January 2026

The session recordings are now available on our website and can be accessed by logged-in members.

Dear VPH Member,

our society now fully operates under vph-society.org, and all communications are sent from this domain. All VPH email addresses have changed from ...@vph-institute.org to ...@vph-society.org. Even thought emails sent to the old addresses will still be received, we recommend adding our new email domain to your contacts or safe-sender list so you don’t miss any announcements.

We also kindly ask all members to finalise their membership renewal for the new year by creating or activating their account on our new website. This will ensure uninterrupted access to member benefits, updates, events, and resources.

For any doubts you might have on the process, please visit our FAQ section.

Thank you for being a valued part of our community — we look forward to another productive year together.

Warm regards,
The VPH Team

POLICY

FDA Releases Key Guidance Updates

The U.S. Food and Drug Administration (FDA) has recently published several guidance documents and policy updates that clarify and modernize regulatory expectations across digital health, medical devices, real-world evidence, and clinical trial design.

Guiding Principles of Good AI Practice in Drug Development

The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence.

EU MDCG Publishes Key 2025 Guidance on Breakthrough Devices and Post-Market Surveillance

The European Union’s Medical Device Coordination Group (MDCG) has issued two important guidance documents in late 2025, providing clarity and support for stakeholders navigating the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) frameworks.

EMA advances 3Rs in regulatory testing

The agency’s 3Rs Working Party published its biennial report for 2023–2024, highlighting progress in promoting alternatives to animal testing while safeguarding scientific quality and animal welfare.

COMMUNITY

VPH Executive Committee Interview Series: Prof. Pinaki Bhattacharya on Engagement with Societies

Prof. Bhattacharya, Associate Professor of Solid Biomechanics at the Insigneo Institute - Sheffield, speaks about the strategic importance of interdisciplinary collaboration, the future of musculoskeletal modelling, and the growing role of in silico methods in clinical decision-making and regulation.

Be the next to organise VPH2028

Elevate your institution’s profile by organising our biannual international conference, the flagship event of the in silico medicine community.

Submission deadline: 13 March 2026.

VPH2026 Conference: Sponsorship & Exhibition Opportunities

A number of opportunities are now open for industry partners seeking meaningful visibility and collaboration at the flagship event of the in silico medicine community.

InSilicoHealth video series: “What is a digital twin for health?”

The Doctoral Candidates at InSilicoHealth have created a series of accessible and engaging videos that explain digital twins for a wide range of audiences including patients, clinicians, industry professionals and policymakers.

In the literature: January 2026 highlights

Discover the recently published papers from our community!

IN THE SPOTLIGHT

Let's talk about sex

Precision medicine promises care tailored to the individual, but long-standing sex and gender biases still shape data, models, and outcomes. Could in silico medicine make healthcare equally precise for all?

Click here

THE DIGITAL TWIN THEORY PODCAST

EP 19: Communities at the heart of healthcare

Healthcare is about people as much as science. In this episode, we talk with Jude Dzevela Kong, Director of AIMMLab at the University of Toronto and Co-Director of ACADIC, about community-driven approaches to healthcare innovation.

Click here

YOUNG SCIENTISTS

Young Scientists Committee: What’s ahead in 2026

The second and final year of the current Young Scientists Committee kicks off with new webinars, podcast contributions, community spaces, and long-term initiatives designed to support VPH student members throughout their early scientific careers.

Join our Slack channel for young scientists!

To further strengthen engagement among student members, VPH has launched a new public Slack channel dedicated to the Young Scientists community. This space will allow students to ask questions, exchange ideas, and actively contribute to YSC activities. Access is open to all our student members.

We are a vibrant ecosystem bringing in silico medicine

from fundamental research to patient care.

Join us!

Subscribe

Subject: VPH newsletter - January 2026

FDA Releases Key Guidance Updates

The U.S. Food and Drug Administration (FDA) has recently published several guidance documents and policy updates that clarify and modernize regulatory expectations across digital health, medical devices, real-world evidence, and clinical trial design.

Guiding Principles of Good AI Practice in Drug Development

The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence.

EU MDCG Publishes Key 2025 Guidance on Breakthrough Devices and Post-Market Surveillance

The European Union’s Medical Device Coordination Group (MDCG) has issued two important guidance documents in late 2025, providing clarity and support for stakeholders navigating the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) frameworks.

EMA advances 3Rs in regulatory testing

The agency’s 3Rs Working Party published its biennial report for 2023–2024, highlighting progress in promoting alternatives to animal testing while safeguarding scientific quality and animal welfare.

VPH Executive Committee Interview Series: Prof. Pinaki Bhattacharya on Engagement with Societies

Be the next to organise VPH2028

InSilicoHealth video series: “What is a digital twin for health?”

In the literature: January 2026 highlights

Let's talk about sex

Precision medicine promises care tailored to the individual, but long-standing sex and gender biases still shape data, models, and outcomes. Could in silico medicine make healthcare equally precise for all?

EP 19: Communities at the heart of healthcare

Healthcare is about people as much as science. In this episode, we talk with Jude Dzevela Kong, Director of AIMMLab at the University of Toronto and Co-Director of ACADIC, about community-driven approaches to healthcare innovation.

Young Scientists Committee: What’s ahead in 2026

Job Board January 2026

EUHPP Live Webinar: AI as a facilitator for realizing the vision of the Virtual Human Twin

Digital Health World Congress 2026

DT4PH 2026 Event

WCB2026 - World Congress of Biomechanics

EMBC 2026 Event

BMT 2026 Conference

Subscribe

Subject: VPH newsletter - January 2026

FDA Releases Key Guidance UpdatesThe U.S. Food and Drug Administration (FDA) has recently published several guidance documents and policy updates that clarify and modernize regulatory expectations across digital health, medical devices, real-world evidence, and clinical trial design.

Guiding Principles of Good AI Practice in Drug DevelopmentThe European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence.

The European Union’s Medical Device Coordination Group (MDCG) has issued two important guidance documents in late 2025, providing clarity and support for stakeholders navigating the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) frameworks.

The agency’s 3Rs Working Party published its biennial report for 2023–2024, highlighting progress in promoting alternatives to animal testing while safeguarding scientific quality and animal welfare.

Let's talk about sexPrecision medicine promises care tailored to the individual, but long-standing sex and gender biases still shape data, models, and outcomes. Could in silico medicine make healthcare equally precise for all?

EP 19: Communities at the heart of healthcare

Healthcare is about people as much as science. In this episode, we talk with Jude Dzevela Kong, Director of AIMMLab at the University of Toronto and Co-Director of ACADIC, about community-driven approaches to healthcare innovation.

FDA Releases Key Guidance Updates

The U.S. Food and Drug Administration (FDA) has recently published several guidance documents and policy updates that clarify and modernize regulatory expectations across digital health, medical devices, real-world evidence, and clinical trial design.

Guiding Principles of Good AI Practice in Drug Development

The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence.

Let's talk about sex

Precision medicine promises care tailored to the individual, but long-standing sex and gender biases still shape data, models, and outcomes. Could in silico medicine make healthcare equally precise for all?